Brief: Alzamend Neuro Partners With The Miller School Of Medicine
28/12/2022 13:07
Dec 28 (Reuters) - Alzamend Neuro Inc ALZN.O :
* ALZAMEND NEURO PARTNERS WITH THE MILLER SCHOOL OF
MEDICINE,
INTERDISCIPLINARY STEM CELL INSTITUTE AT THE UNIVERSITY OF MIAMI
FOR ALZN002 PHASE I/IIA IMMUNOTHERAPY VACCINE CLINICAL TRIAL TO
TREAT MILD TO MODERATE DEMENTIA OF THE ALZHEIMER’S TYPE
Source text for Eikon: ID:nBw9lnFjWa
Further company coverage: ALZN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Alzamend Neuro
See all newsAlzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 56 cents a share - Earnings Preview
Alzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview